All right guys hear me out hear me out: this is the best spot that i could put that camera. So if you guys uh, if you guys don't like the placement, i apologize, i apologize. It was either this or just the presentation so uh. What is up, everybody welcome to trey's trades.

We get technical analysis and different stocks in the stock market, as well as potential buy holders, sell opinions on these given stocks, electric pipes by saying that i'm not a financial advisor nor expert so take what i say with a grain of salt. The reason i started this channel because a couple years back was about 30 000 deep in some medical debt, and i was very fortunate to have some close family friends and mentors that pushed me to work hard and invest my money and i'm happy to say that Not only am i not financially free, but i'm doing pretty well for myself at the age of 23.. So if i can pass along any of the information resources or tools that are given to me and make the community a little bit better off than it was before, that's all that i can ask for last. If you would not mind drop a like on the video, it does help support the channel and consider subscribing if you like, to see more content like this now today we're going to be giving a video about all the due diligence you need for zone.

I do have a position in zoma, i'm holding about four thousand dollars in zone right now, and i will be holding this at least until the end of march and potentially longer as we do a little more reading. As we do have some new financial statements that come out regarding the company as their true forma, does begin to evolve and we see how it commercializes, but with that being said, this is going to be a due diligence, video for you all the dd. You need for zone the gd. Let's do it.

I just thought that b was cool. It's a cool animation. I figured you know it's pretty light-hearted, whatever so zometica fundamentals. What is zometica, there are clinical veterinarians, creating products for clinical veterinarians, so um with colbit, and with this cobit you know the quarantine that has been happening.

There has been an evolving demand for pets, uh, just my own personal life. I can think of a bunch of people who have gotten a cat, a dog, a bird uh. You know all sorts of different things and with an evolving demand for pets, comes in an evolving demand for pet health right, so taking care of your shots, making sure that their thyroids are good to go any sort of diseases. They might have.

There's a lot of different things that that zometica focuses on that will apply to these pets, and i think the market here is going to extremely evolve and there is a high demand and very little competition. I think so. Medica is going to be able to really capitalize on a niche market, so they do have products for companion, animals and the big thing that we're waiting on in march 30th - and i will touch on this later, his true forma - and this is going to be a Huge asset to the company - and i personally think they're going to likely create a patent on the truforma system and patents are a way that we know. Companies are guaranteed to have generated revenue and cash flow throughout years and years and years to come.

So if they do end up creating a patent entry format, i will update as always, but that would be a very positive thing for the company, as it would give them complete rights to this true forma system. So what is truforma? I pulled this right off the website: trueforma introducing highly sensitive species, specific assays for the diagnosis of thyroid disease and dogs and cats and adrenal disease in dogs. True former delivers the accuracy and performance you demand with the convenience and ease of use. You need complete thyroid and adrenal results within the patient.

Visit means less stress for pets, pet owners and the veterinary health care system, and we are expected to see this true forma commercialized in late march. So, there's a lot of anticipation in the price action with true forma. Currently, i will just show you really quick what the price action is looking like with uh with zone. Let me just pull this up and it has been growing a lot.

Of course, we have had some new outside news catalyst that has, you know, affected the stock price, uh cara baskin from the tiger king, putting out that uh that paid endorsement on on zone for 299 or whatever. I don't know why she did that for 299 dollars. That's so dumb, but we definitely. You know we had a little bit of help right, but it is growing exponentially.

The charts look extremely bullish, you know just about two weeks ago we were trading at 24 cents and at one point we touched 1.48, and that is all the proof that i need to see that people are interested in the stock. Is the overall charts right? I do focus on technical analysis, but there is a lot of good things happening here on the fundamental side of things: news, catalyst, growth, financial statements. We are expecting a lot to happen with zone and it does back up what we're seeing on the charts, which is a lot of bullish action. So this is a great bullish case for zone and we will just continue along with the presentation so true format.

They do have test performance and case management, so what this is focusing on is you know with their their thyroid and uh adrenal gland. You know focus with this true forma system. We are expecting to be able to manage cases, and this is something that i could see getting commercialized for use at home uh. Of course, this will be.

You know focused primarily on veterinarians right in veterinarian practices, but they could push this forward as potential to commercialize. It not just for you know, medical use, but for home use right and if they create a patent on this, they could sell this as a product and it would evolve and generate revenue towards this company with a lot of time to come. So this has a lot of potential for sure. The thyroid and adrenal results with inpatient visit uh.

They do have some really positive results with truforma in some studies and some case studies that they've specifically focused on with this true form of system. Now i have had people comment on some of these zone videos before saying: why did you tell people to get into this? Their history is terrible right. They don't make money they're negative. You know cash balance et cetera, et cetera.

This is a penny stock guys. There is risk involved with with a company like zone, but i do think the upside in the next year or in the next couple months is extremely high and i'll present my case on that later. But they have a lot of positive catalysts and the true format is a huge one. Another thing that transformer has is disposable acid cartridges to test thyroid and adrenal analytes in 20 minutes or less.

So it's a very fast-acting system. You can dispose of the cartridges that that test out your pets, your cats, your dogs, uh. It is a great system from what i've read online and you feel free to fact check me if you'd like, but true formula has a lot of potential, and i can see this being something that gets commercialized that gets pushed out that they can sell. They can collect profits off of, and i think it's a very niche market, where there's not a lot of companies doing what uh.

What zometica is doing right and with the increasing demand for for cats and dogs and pets will come an increase in demand for keeping them healthy, so uh continue. They do have an evolving test menu, the bulk acoustic wave tech. So this is a that's type of tech that is utilized by the truforma system. Uh, i'm not very familiar with what the bulk acoustic wave is, but it is a means in which they they uh.

They use the system so that it gets you the results. You need on the thyroid and the adrenal gland and you can keep your pets healthy in that way and then the disposable asset cartridges, as i had mentioned prior, it's uh. It's it's easy to clean up, it's a very easy to use system. That's why we talk about the evolving test menu.

They are currently still working through the products on this but um. It seems like it's a very user friendly system that uh people will be able to buy and keep it their own house and generate revenue off of, and this is going to be one of those products guys where um. I can see word of mouth really spreading. This up, where the company could extremely grow uh, just based on the success rates right, like people are very attached to their animals.

Uh we've begun to realize more and more that, as covet has evolved and quarantine has grown longer and longer that without human contact we need some sort of contact right and people really begin to appreciate and and make their pets a part of their family. And, like i said, i know a lot of people that have gotten cats or dogs and they that's, it's been their sole driver of of uh. You know feeling satisfied and happy in life and with this true form of system, uh it'll help keep these pets healthy, because the last thing you want is a cat. You got it at six months old or something that's a year old and all of a sudden.

It's got a thyroid issue and it passes away because you couldn't take care of it right, so this is going to help with that very niche market. So the relevance right, evolving need for pet health and quarantine. Uh play that's zero. Zom is the play here.

It just seems like a good company, i mean when you think about something you want to hold for a midterm or a long term investment. You want to make sure that you have really strong conviction and that there is a need for the company right in a traders market. You know if you're swinging, something you know. Maybe it doesn't matter as much what the company's doing right, because at the end of the day, you're paying attention to the psychology of investors and traders you're paying attention to the sentiment of traders right.

But here we're thinking about the potential for the company, which is why i'm not overly concerned about previous financial statements with uh with zometica, because there is an evolving need for pet health and and with quarantine. More and more people are getting pets and that's not they're. Not just going to get rid of them once quarantine's over right, there's still going to be a need to keep them healthy. So i can see this being a great two.

Three four year hold in the future and i will update as always, but at the very least, i think this is a great hold up until march, as it should continue to rise. I do think it's gon na be a four or five dollar stock in march, and i will touch on that later, but it's a very disruptive second sector in the industry, there's very little competition investor sentiment is going up as we have seen the stock price climb. Uh, regardless of the fact that this true form of commercialization is not expected to happen until march 30th, which is a very long time away, which tells you right now that investors have a great feeling about the company. They see a lot of potential in growth and it tells you a lot about the psychology and the sentiment towards the company.

That's high, and you know this because of the price action right. We went from 24 cents all the way up to a dollar fifty in about a week and um. That's all you need to know about the charts to say that hey people think high levels of medica, whether you want to admit it or not whether you want to look at uh. You know previous financial statements, previous company management, uh previous uh, previous anything regarding this company.

At this current moment, people feel good about zometica, whether you agree with that or not the majority of investors and of traders are getting into this play and for good reason. So there is a growing desire for pets and pet health, as i mentioned earlier crucial date, march 30th is when we were expecting the true form of commercialization and uh. I expect as we you know, approach march and we get closer to that crucial date. We are going to see a harder push in uh in anticipation for that commercialization, for things to go well right, so i think, as we get closer to march, if you want to wait until then to get into this play, you can feel free to do so, But i do recommend getting into this while it is still under a dollar because once it gets over a dollar and it holds for over 10 days, that is going to pass the nasdaq compliance rule in which you need to have a stock over one dollar.

Otherwise, they're a risk of going to the otc market and uh once it holds over a dollar that is going to attract new investors right because there are some people who won't touch with stock under a dollar to invest in right, because the risk is too high. For them, which makes total sense, i understand that and as it holds over a dollar you're going to attract new investors, and that is just further going to push the price action on this in an upward uh direction. And i i can really highly see this touching. Four or five dollars, i'm lowballing you anyone that's been in the part of this channel for a while knows that i don't like to get people's hopes up and i think four or five dollars by the end of march is extremely realistic.

Another management team - i was pulled up to four top management people, and it's in it's in order here. So one two, three four down the list: robert cohen, is the medical device, pharmaceutical and biotech background um part of the management team. He is the ceo and he has a large background in medical services, so he he works a lot with uh. You know the tech side of the truforma system uh the pharmaceutical side of the performance system, because in order to be able to utilize this performance system right, you need to have a background on thyroid.

You need to have a background on the adrenal gland. You need to have a background of the chemistry and the biology of what you need in order to test these things, and robert cohen has a very strong background in all three all those things. Stephanie morley is an innovation strategies and business opportunities, uh piece of the management team she's, the chief medical officer, so she works a lot with uh. You know different business transactions talking with investors or uh.

You know institutional investors and bringing to their attention. The potential of this stock and i think, she's doing a pretty good job, as we have seen a lot of push. You know, months out still from uh from this march 30th date for the stock to increase in valuation and cotter. Right here is the prior cfo of american fence company and has a long history of being a cfo, and that's the chief financials officer and uh.

That background to me is comforting, because when you bring in a new management right, that brings a little bit of concern of. Does it? Do they know what they're doing do they have any sort of background um and with her prior service in this american fence company? It sounds exactly like it is, it is a. It is a company that focused on the commercialization and the sale of fences. Right she's got a lot of different backgrounds here, so she has prior experience that speaks on uh.

Her ability to push for you know an increase in you, know good financial situations within zometica, and that should give investors and buyers confirmation that hey things are going to look pretty. Well, i don't remember the exact date there was on the website if you'd like to check it out, but i think it was 2013 is uh is when she moved away from this american fence company, and i feel really good about her being the cfo over here. At zlmedico and then brooke herbst is the marketing customer support and commercial strategy. Um piece of the management team he's a cco which is the chief commercial officer, and he is in charge of the commercialization he's the granddaddy in charge of uh.

It's funny because he kind of he's bald um. That's not why it's funny! Oh man, where am i going with this uh i'll, just get right back to the video he he's in charge of the commercialization of the product, so that true format is going to be his baby he's going to make sure that this gets into the eyes of All the people that need to see it he's going to make sure that it gets into the eyes of all the people who need to buy it he's going to be in charge of the marketing. The customer support he's going to manage that piece of things and i like how well-rounded they are. They have a nice background.

They've got that medical biopharmaceutical biotech background here. Right they've got a couple: different people working on innovation strategies and business opportunities, financials and then marketing right. So they've got a really well-rounded management team. I feel really solid about where they're heading here so the financials.

I did find this on yahoo analysis, that page of zometica - and i find this pretty interesting - there's not a lot of analysts that are talking about this stock and don't be scared by that. What that signifies to me is that uh we're kind of beating the hype with this play here. I think a lot of the wall street or the institutional buyers are still sleeping a little bit on zometica and that's an opportunity for us to get ahead of the big buyers right. Guys, like you and me who are playing with if you've got less than a million dollars or even 10 million dollars, you know these guys are playing with hundreds of millions of dollars and and we're beating the hype there and once they get into the play.

It should be pretty freaking crazy, so i do have pulled up the estimate for uh all of these time periods. So we've got current december 2020 march, 2021, 2020 and then 2021, and you know i will talk about this in the next slide. But um. The average estimate is not available for 2020, but we are expecting march 2021 to have a 400 000 uh average revenue and then 2021 is 4.8 million dollars, and this is really really important because of course this is just speculative.

This is information that i found on yahoo finance. Um they'll have to back up their their own piece of this, but this could be huge because um, their overall revenue currently is zero dollars as of 2019., and that's why people rag on on zone for the fact that hey? Why are you telling people to buy this? Their history does not look good right. They don't have a lot to back up uh all this growth. They don't have anything in their past to to say hey.

This is a good buy, but you're not investing in this. For their previous history right, if that's the way that price action worked, charts would almost never grow for penny stocks because you're not investing in their previous growth you're investing in the potential for growth right if you're investing in their previous growth, you might as well get Into apple, because apple has already proven that it's successful, that's why it's a multi-hundred dollar stock you might as well get into amazon! That's why it's a three thousand plus dollar stock, because people know what it is right most penny plays, that you find in the market. Are not going to have great previous financial systems or previous financial statements, i should say um you're, investing in the idea that they're going to grow and that's why it's a penny stock. And if this 4.8 million dollar estimate for 2021 does come to fruition from their zero dollar total revenue currently as of 2019, that is going to absolutely crush the stock guys, that's insane! I mean if we look at the market cap right now.

Their market cap is 550 million dollars and if we're assuming they're going to grow through 4.8 million dollar revenue, that is going to push the market cap up a lot, i can see this very easily becoming a one billion dollar market cap company just by march alone, And if we look a year down the road two years down the road, two three four billion dollar market cap is not out of the question and if you just simply take you know the overall price on zone at 97 cents at a 550 million dollar market Cap and you multiply that by four we'll, just lowball this and say a two billion dollar market cap in a year right, you're, looking at a four dollar stock and i think that zone is currently undervalued either that or jag x is overvalued. And i brought this comparison up because i think it's very interesting. Jagex is a 426 million dollar market cap company and they were trading at three dollars and 37 cents. Zom has a higher overall market cap and is currently trading at 97 cents just under a dollar right.

So i think there's a lot of room to run with zom. I think that this is just starting to get brought to some people's attention and, as it continues to grow, this is not a play that you guys want to get left out on. I am not selling any of my shares uh. There was a point in time which i was up.

You know about 80 on this, and now i'm only up about 40 and i'm not sweating an inch right. I'm not getting rid of this because think about this. The roth ira guy can get you a 10 return every year on a great year on your on your off right. If you can make four or five or six hundred percent on this stock between now and march, or even more than that from now to december of the end of the year right, a thousand percent we're just let's just look we're just throwing numbers out there right Now why would you not wait it out? You know so to me it is speculative right, any penny.

Any penny stock there is risk that you lose everything you put into it, but all this catalyst, all the the upcoming things that we're expecting should completely trump everything that we've seen in the past. You know a year, two years, three years that's happened with zometica. I feel extremely good about what's happening here and if jagex can do this, i see no reason why dom can't do the exact same. So what's the potential upside here right, as i mentioned earlier, the total revenue as of 2019, was zero dollars.

They didn't make any money right there. They were a uh, you know a base phase company working on building out their fundamentals, building out their financials building out the performance system and their operating income was negative, 19 million dollars. So you're investing into a company who has had previous, you know not a lot of success, but we're expecting a lot of success right. So look at this.

This is very interesting. They have a total cash position of 550 million dollars, even though their operating income was negative. 19 million dollars we're expecting to generate 4.8 million dollars in revenue they're, sending out a lot of cash right now, and that to me is a very positive sign, because that means that they have a lot of money to work with to continue to evolve. Their true form of system - and there should be a lot of growth potential involved with uh with zometica and guys.

I hope that this is uh. This is opening your eyes a little bit to why there's so much hype surrounding this. Why i'm not selling until at least march potentially longer? This might be a sock that i just said and forget it with forever, because i think, as colvin and quarantine ends, people are still going to have their pets. There's still going to be a demand for healthy pets, there's still going to be a demand for uh this truforma system.

This is going to be revolutionary if you can get this into the hands of just regular people get this into their homes. Um. The upside here is a lot higher than the potential downside worst case scenario here, guys right. If you put five thousand dollars into zometica and it drops back down to zero, you lost five thousand dollars.

But if you get into this right now at 97 cents and you lose five thousand dollars, that's the downside and the upside is 10xing your money at the end of the year, which is it worth it to you? Would you would you put your 5 000 into this? My answer is yes, you know um and that's that's my that's my bullish case on zometica, so uh just so, i'm going to take a quick look at the charts. Just to give you some double confirmation. It's extremely bullish. Right now, we've been on an absolute rampage, filthy run, uh, they're they're in extremely bullish territory, the 15 vomits trading over the 200 ema.

We have been in overbought territory very frequently. The sentiment on this stock is extremely high and i do see them continuing to grow leading into that late march date, so that is my bullish case on zometica. If you guys have any questions, i will do my best to get back to them. If you drop it in the comments section, if you enjoyed the video, please drop a like, it really does help support the channel and consider subscribing if you like, to see more content like this, as i do post videos every day.

So that's what i have for you guys today. Thank you for watching my friends and i'll see you all next time. Peace.